These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 22262882)

  • 1. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
    Volkow ND; Wang GJ; Tomasi D; Kollins SH; Wigal TL; Newcorn JH; Telang FW; Fowler JS; Logan J; Wong CT; Swanson JM
    J Neurosci; 2012 Jan; 32(3):841-9. PubMed ID: 22262882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
    Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
    Wang GJ; Volkow ND; Wigal T; Kollins SH; Newcorn JH; Telang F; Logan J; Jayne M; Wong CT; Han H; Fowler JS; Zhu W; Swanson JM
    PLoS One; 2013; 8(5):e63023. PubMed ID: 23696790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Telang F; Maynard L; Logan J; Gatley SJ; Pappas N; Wong C; Vaska P; Zhu W; Swanson JM
    Am J Psychiatry; 2004 Jul; 161(7):1173-80. PubMed ID: 15229048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of methylphenidate: insights from PET imaging studies.
    Volkow ND; Fowler JS; Wang G; Ding Y; Gatley SJ
    J Atten Disord; 2002; 6 Suppl 1():S31-43. PubMed ID: 12685517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
    Quinn D
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N; Fryer TD; Hong YT; Smith R; Brichard L; Acosta-Cabronero J; Chamberlain SR; Tait R; Izquierdo D; Regenthal R; Dowson J; Suckling J; Baron JC; Aigbirhio FI; Robbins TW; Sahakian BJ; Müller U
    Brain; 2013 Nov; 136(Pt 11):3252-70. PubMed ID: 24163364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Fowler JS; Ding YS
    Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in methylphenidate-induced dopamine increases in ventral striatum.
    Manza P; Shokri-Kojori E; Wiers CE; Kroll D; Feldman D; McPherson K; Biesecker E; Dennis E; Johnson A; Kelleher A; Qu S; Tomasi D; Wang GJ; Volkow ND
    Mol Psychiatry; 2022 Feb; 27(2):939-946. PubMed ID: 34707237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.
    Volkow ND; Wang G; Fowler JS; Logan J; Gerasimov M; Maynard L; Ding Y; Gatley SJ; Gifford A; Franceschi D
    J Neurosci; 2001 Jan; 21(2):RC121. PubMed ID: 11160455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.
    Boileau I; Dagher A; Leyton M; Gunn RN; Baker GB; Diksic M; Benkelfat C
    Arch Gen Psychiatry; 2006 Dec; 63(12):1386-95. PubMed ID: 17146013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is increased D2 receptor availability associated with response to stimulant medication in ADHD.
    Ilgin N; Senol S; Gucuyener K; Gokcora N; Sener S
    Dev Med Child Neurol; 2001 Nov; 43(11):755-60. PubMed ID: 11730150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Rösler M; Fischer R; Ammer R; Ose C; Retz W
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):120-9. PubMed ID: 19165529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):959-68. PubMed ID: 25395383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate.
    Buitelaar JK; Casas M; Philipsen A; Kooij JJ; Ramos-Quiroga JA; Dejonckheere J; van Oene JC; Schäuble B
    Psychol Med; 2012 Jan; 42(1):195-204. PubMed ID: 21733214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.